Ibogaine vs. Iboga Alkaloids for Treating Addiction
Novel chemical variants of ibogaine may offer therapeutic benefits without severe side effects.
Articles - Page 14
What is the Mystical Experience Questionnaire?
The MEQ is a self-report measure that provides insight into a key aspect of the psychedelic experience.
The Effects of Psilocybin on Morality and Empathy
This study is the first of its kind to suggest that psilocybin enhances emotional empathy but does not affect moral behavior.
Hamilton Morris Synthesizes 5-MeO-DMT in “Pharmacopeia”
“I believe one person can produce enough 5-MeO-DMT to supply everyone that would ever want it.”
Are the Subjective Effects of Psychedelics Necessary for Their Therapeutic Benefits?
Researchers at the forefront of psychedelic science put forth their arguments in this important debate.
The Top 10 Psilocybin Research Papers of 2020
Changes in brain functioning, new synthesis methods, and psychotherapy dominate this year’s most-cited psilocybin papers.
Compassionate Use – Psychedelic Therapy for Those Who Can’t Wait
“Obviously, bureaucracy is not a human being. People have compassion. Bureaucracies don’t always have compassion.' -- Spencer Hawkswell
Editor’s Choice Award – Best Psychedelic Chemistry/Synthesis Study of 2020
This study provides meaningful access to some lesser-known magic mushroom compounds and conducts biological testing on them for the first time.
Equity and Accessibility of MDMA-Assisted Therapy
Psychedelic medicine continues to move forward, but minority communities are being left behind.
Exploratory Study Indicates Psilocybin Provides Relief for Migraines
Interestingly, changes in migraine frequency were not correlated with the intensity of the acute psychotropic effects.